299 related articles for article (PubMed ID: 26958922)
1. Novel Functions of the Human Papillomavirus E6 Oncoproteins.
Wallace NA; Galloway DA
Annu Rev Virol; 2015 Nov; 2(1):403-23. PubMed ID: 26958922
[TBL] [Abstract][Full Text] [Related]
2. Protein intrinsic disorder and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs.
Uversky VN; Roman A; Oldfield CJ; Dunker AK
J Proteome Res; 2006 Aug; 5(8):1829-42. PubMed ID: 16889404
[TBL] [Abstract][Full Text] [Related]
3. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
[TBL] [Abstract][Full Text] [Related]
4. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
[TBL] [Abstract][Full Text] [Related]
5. Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.
Chakrabarti O; Krishna S
J Biosci; 2003 Apr; 28(3):337-48. PubMed ID: 12734411
[TBL] [Abstract][Full Text] [Related]
6. The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length.
Stöppler H; Hartmann DP; Sherman L; Schlegel R
J Biol Chem; 1997 May; 272(20):13332-7. PubMed ID: 9148955
[TBL] [Abstract][Full Text] [Related]
7. Roles for E1-independent replication and E6-mediated p53 degradation during low-risk and high-risk human papillomavirus genome maintenance.
Murakami I; Egawa N; Griffin H; Yin W; Kranjec C; Nakahara T; Kiyono T; Doorbar J
PLoS Pathog; 2019 May; 15(5):e1007755. PubMed ID: 31083694
[TBL] [Abstract][Full Text] [Related]
8. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.
Scheffner M; Werness BA; Huibregtse JM; Levine AJ; Howley PM
Cell; 1990 Dec; 63(6):1129-36. PubMed ID: 2175676
[TBL] [Abstract][Full Text] [Related]
9. Papillomavirus E6 and E7 proteins and their cellular targets.
Wise-Draper TM; Wells SI
Front Biosci; 2008 Jan; 13():1003-17. PubMed ID: 17981607
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation.
Mittal S; Banks L
Mutat Res Rev Mutat Res; 2017; 772():23-35. PubMed ID: 28528687
[TBL] [Abstract][Full Text] [Related]
12. The Role of E6 Spliced Isoforms (E6*) in Human Papillomavirus-Induced Carcinogenesis.
Olmedo-Nieva L; Muñoz-Bello JO; Contreras-Paredes A; Lizano M
Viruses; 2018 Jan; 10(1):. PubMed ID: 29346309
[TBL] [Abstract][Full Text] [Related]
13. Papillomavirus E6 proteins.
Howie HL; Katzenellenbogen RA; Galloway DA
Virology; 2009 Feb; 384(2):324-34. PubMed ID: 19081593
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis.
Ganguly N; Parihar SP
J Biosci; 2009 Mar; 34(1):113-23. PubMed ID: 19430123
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of human papillomaviruses in differentiating epithelia.
Longworth MS; Laimins LA
Microbiol Mol Biol Rev; 2004 Jun; 68(2):362-72. PubMed ID: 15187189
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins.
Duensing S; Münger K
Int J Cancer; 2004 Mar; 109(2):157-62. PubMed ID: 14750163
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Cellular Metabolism by High-Risk Human Papillomaviruses.
Martínez-Ramírez I; Carrillo-García A; Contreras-Paredes A; Ortiz-Sánchez E; Cruz-Gregorio A; Lizano M
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29932118
[TBL] [Abstract][Full Text] [Related]
18. Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins.
Haręża DA; Wilczyński JR; Paradowska E
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163748
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus immortalization and transformation functions.
Münger K; Howley PM
Virus Res; 2002 Nov; 89(2):213-28. PubMed ID: 12445661
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of transforming properties of E6 and E7 from different beta human papillomavirus types.
Cornet I; Bouvard V; Campo MS; Thomas M; Banks L; Gissmann L; Lamartine J; Sylla BS; Accardi R; Tommasino M
J Virol; 2012 Feb; 86(4):2366-70. PubMed ID: 22171257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
